An uncommon histopathological diagnosis.

Authors :: Bode H
Sciot R
Werbrouck E
Geusens E
Deroose CM
Nackaerts K
Source :: Breathe (Sheffield, England) [Breathe (Sheff)] 2018 Dec; Vol. 14 (4), pp. 311-316.
Publication Year :: 2018
Abstract: Can you perform a robust histopathological diagnosis for this unusual case?  http://ow.ly/40GB30mc5Th.<br />Competing Interests: Conflict of interest: H. Bode has nothing to disclose. Conflict of interest: R. Sciot has nothing to disclose. Conflict of interest: E. Werbrouck has nothing to disclose. Conflict of interest: E. Geusens has nothing to disclose. Conflict of interest: C.M. Deroose reports consultancy fees from Bayer, Sirtex, Novartis Pharma and Advanced Accelerator Applications (AAA), and advisory board fees from Ipsen, Novartis Pharma and Terumo, all outside the submitted work. Conflict of interest: K. Nackaerts has nothing to disclose.